European equities traded in the US as American depositary receipts were climbing higher Thursday morning, rising 1.19% to 1,475.61 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk (NVO) and semiconductor company Sequans Communications (SQNS), which rose 6.2% and 4.3% respectively. They were followed by EDAP TMS (EDAP) and biopharmaceutical company Genfit (GNFT), which were up 4.3% and 3.9% respectively. medical device maker

The decliners from continental Europe were led by internet advertising firm Criteo (CRTO) and telecommunications operator Telefonica (TEF), which were down 1.9% and 0.7% respectively. They were followed by internet browser company Opera (OPRA) and oil and gas company Eni (E), which lost 0.7% and 0.6% respectively.

From the UK and Ireland, the gainers were led by hospitality company InterContinental Hotels Group (IHG) and biopharmaceutical companies Biodexa Pharmaceuticals (BDRX), which increased 7% and 5.1% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and Adaptimmune Therapeutics (ADAP), which advanced 4.3% and 2.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and pharmaceutical company Silence Therapeutics (SLN), which dropped 7.7% and 1.9% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and communications company WPP (WPP), which fell 1.9% each.